Regulatory Manager - Pharmaceuticals

This is an exciting opportunity to join a growing pharmaceutical regulatory function within one of the UK's leading academic research organisations. As UCL's clinical trial portfolio continues to expand, we are recruiting to an additional Regulatory Manager - Pharmaceuticals post to strengthen the team and support the next generation of groundbreaking therapies and technologies.

We are looking for a highly specialist pharmacist with experience in clinical trials, pharmaceutical manufacturing, or regulatory affairs and someone who is passionate about advancing clinical research and helping bring innovative therapies from development to patients.Working closely with trial teams, regulators and industry partners, you will help ensure studies are delivered on behalf of UCL sponsored studies.

As the regulatory pharmaceutical expert, you will support all aspects of IMP sourcing, manufacturing, Chemistry, Manufacturing and Control (CMC) strategy, and regulations across Phase 1-3 clinical trials.

This role offers an excellent opportunity to develop expertise in the regulatory and CMC aspects of clinical trials, particularly early-phase and innovative therapies. You will support compliance with UK and EU regulations, GCP and GMP requirements, while providing specialist pharmaceutical advice to investigators and study teams. This is an exciting opportunity to work at the forefront of clinical research within a world-leading academic institution., The post holder will provide expert regulatory, pharmaceutical and IMP support for UCL-sponsored CTIMPs, particularly studies where the Sponsor is responsible for IMP manufacture and supply. Working closely with study teams, they will support the development of CMC strategies, including manufacturing, testing, release and supply chain models, identification of suitable pharmaceutical vendors and CDMOs, and determination of CTA documentation requirements based on study phase, product type and complexity.

The role includes reviewing and approving GMP and pharmaceutical documentation, supporting responses to regulatory authority queries, and providing advice on complex CMC and regulatory challenges. The post holder will lead on the development and review of quality agreements and oversight of outsourced manufacturing and testing activities.

The post holder will support complex studies, including early-phase and first-in-human trials involving cell and gene therapies, biologics, radiopharmaceuticals and small molecules. They will act as a key point of contact for investigators, trial teams, manufacturers and site pharmacies on pharmaceutical and regulatory matters.

The role also includes participation in the UCL JRO Scope Review Committee, supporting classification of studies as CTIMPs or non-CTIMPs. Subject to funding, the post holder may undertake national and international travel, including GMP audits and due diligence assessments of manufacturing and testing facilities.

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites:

University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)

National Hospital for Neurology and Neurosurgery

Royal National ENT and Eastman Dental Hospitals

University College Hospital Grafton Way Building

Royal London Hospital for Integrated Medicine

University College Hospital Macmillan Cancer Centre

The Hospital for Tropical Diseases

University College Hospital at Westmoreland Street

We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.

We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.